AU9026691A - New human recombinant gamma interferon - Google Patents
New human recombinant gamma interferonInfo
- Publication number
- AU9026691A AU9026691A AU90266/91A AU9026691A AU9026691A AU 9026691 A AU9026691 A AU 9026691A AU 90266/91 A AU90266/91 A AU 90266/91A AU 9026691 A AU9026691 A AU 9026691A AU 9026691 A AU9026691 A AU 9026691A
- Authority
- AU
- Australia
- Prior art keywords
- human recombinant
- gamma interferon
- concerns
- new human
- new
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000008070 Interferon-gamma Human genes 0.000 title 1
- 108010074328 Interferon-gamma Proteins 0.000 title 1
- 229940044627 gamma-interferon Drugs 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 abstract 4
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 108020004414 DNA Proteins 0.000 abstract 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000012847 fine chemical Substances 0.000 abstract 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 229940079322 interferon Drugs 0.000 abstract 1
- 229930182817 methionine Natural products 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
- 238000000734 protein sequencing Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/57—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4036856 | 1990-11-19 | ||
| DE4036856A DE4036856C1 (enExample) | 1990-11-19 | 1990-11-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU9026691A true AU9026691A (en) | 1992-06-11 |
Family
ID=6418557
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU90266/91A Abandoned AU9026691A (en) | 1990-11-19 | 1991-11-14 | New human recombinant gamma interferon |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0652903B1 (enExample) |
| JP (1) | JP3219274B2 (enExample) |
| AT (1) | ATE163651T1 (enExample) |
| AU (1) | AU9026691A (enExample) |
| CA (1) | CA2096532C (enExample) |
| DE (2) | DE4036856C1 (enExample) |
| DK (1) | DK0652903T3 (enExample) |
| ES (1) | ES2114555T3 (enExample) |
| WO (1) | WO1992008737A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19535853C2 (de) * | 1995-09-18 | 1999-04-01 | Fraunhofer Ges Forschung | Varianten des rekombinanten humanen Interferon-gamma, Verfahren zu ihrer Herstellung und ihre Verwendung |
| DE19604583C2 (de) * | 1996-02-08 | 1999-11-18 | Fraunhofer Ges Forschung | Verfahren zur Synthese von löslichen, rekombinanten Proteinen aus Bakterienzellen |
| JP2003513681A (ja) | 1999-11-12 | 2003-04-15 | マキシゲン・ホールディングス・リミテッド | インターフェロンガンマ・コンジュゲート |
| US7230081B1 (en) | 1999-11-12 | 2007-06-12 | Maxygen Holdings, Ltd. | Interferon gamma conjugates |
| US7038015B2 (en) | 2001-04-06 | 2006-05-02 | Maxygen Holdings, Ltd. | Interferon gamma polypeptide variants |
| US6958388B2 (en) | 2001-04-06 | 2005-10-25 | Maxygen, Aps | Interferon gamma polypeptide variants |
| PL366705A1 (en) * | 2001-04-06 | 2005-02-07 | Maxygen Holdings Ltd. | Interferon gamma polypeptide variants |
| WO2004005341A2 (en) | 2002-07-03 | 2004-01-15 | Maxygen Holdings Ltd. | Full-length interferon gamma polypeptide variants |
| JP7611820B2 (ja) | 2018-10-11 | 2025-01-10 | インヒブルクス バイオサイエンシズ インコーポレイテッド | Ｄｌｌ３シングルドメイン抗体およびその治療用組成物 |
| AU2019356573B2 (en) | 2018-10-11 | 2025-12-18 | Inhibrx Biosciences, Inc. | PD-1 single domain antibodies and therapeutic compositions thereof |
| CN113166261A (zh) | 2018-10-11 | 2021-07-23 | 印希比股份有限公司 | B7h3单域抗体及其治疗性组合物 |
| US12590169B2 (en) | 2018-10-11 | 2026-03-31 | Inhibrx Biosciences, Inc. | 5T4 single domain antibodies and therapeutic compositions thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4855238A (en) * | 1983-12-16 | 1989-08-08 | Genentech, Inc. | Recombinant gamma interferons having enhanced stability and methods therefor |
| IL75302A0 (en) * | 1984-06-06 | 1985-09-29 | Takeda Chemical Industries Ltd | Novel polypeptide and production thereof |
| JPS6124599A (ja) * | 1984-07-11 | 1986-02-03 | Kyowa Hakko Kogyo Co Ltd | 新規ヒトインタ−フエロン−ｒポリペプチド誘導体 |
| GB8619725D0 (en) * | 1986-08-13 | 1986-09-24 | Hoffmann La Roche | Homogenous interferon fragments |
| DE3730331A1 (de) * | 1987-09-10 | 1989-03-30 | Basf Ag | Neue polypeptide, verfahren zur herstellung, die vektoren dafuer und arzneimittel daraus |
-
1990
- 1990-11-19 DE DE4036856A patent/DE4036856C1/de not_active Expired - Lifetime
-
1991
- 1991-11-14 DK DK92900077.6T patent/DK0652903T3/da active
- 1991-11-14 ES ES92900077T patent/ES2114555T3/es not_active Expired - Lifetime
- 1991-11-14 EP EP92900077A patent/EP0652903B1/de not_active Expired - Lifetime
- 1991-11-14 JP JP50025492A patent/JP3219274B2/ja not_active Expired - Fee Related
- 1991-11-14 DE DE59108947T patent/DE59108947D1/de not_active Expired - Lifetime
- 1991-11-14 AT AT92900077T patent/ATE163651T1/de not_active IP Right Cessation
- 1991-11-14 AU AU90266/91A patent/AU9026691A/en not_active Abandoned
- 1991-11-14 WO PCT/DE1991/000912 patent/WO1992008737A1/de not_active Ceased
- 1991-11-14 CA CA002096532A patent/CA2096532C/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO1992008737A1 (de) | 1992-05-29 |
| ATE163651T1 (de) | 1998-03-15 |
| DE4036856C1 (enExample) | 1992-05-27 |
| CA2096532A1 (en) | 1992-05-20 |
| EP0652903A1 (de) | 1995-05-17 |
| JP3219274B2 (ja) | 2001-10-15 |
| EP0652903B1 (de) | 1998-03-04 |
| JPH06502992A (ja) | 1994-04-07 |
| CA2096532C (en) | 2002-12-31 |
| DK0652903T3 (da) | 1998-03-30 |
| DE59108947D1 (de) | 1998-04-09 |
| ES2114555T3 (es) | 1998-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU561343B2 (en) | Human immune interferon by recombinant dna | |
| AU595221B2 (en) | Fusion proteins, a process for their preparation and their use | |
| GR3034492T3 (en) | Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same | |
| HUT54213A (en) | Process for the enzymatic removal of n-terminal sequence of proteins | |
| AU2058888A (en) | Variants of bovine pancreatic trypsin inhibitor produced by recombinant DNA technology, process, expression vector and recombinant host therefor and pharmaceutical use thereof | |
| ES8802161A1 (es) | Procedimiento para la obtencion de peptidos | |
| AU1003888A (en) | Pancreatic secretory trypsin inhibitor and variants thereof produced by a recombinant host, process, expression vector and recombinant host therefore and pharmaceutical use thereof | |
| IL81018A (en) | Fusion proteins comprising small fragments of human interleukin-2 as ballast,process for its preparation and genes,vectors and transformed host containing said fragments and used in the process | |
| DK0652903T3 (da) | Nyt humant rekombinant gammainterferon | |
| AU669483B2 (en) | Nucleotide sequences and resistance proteins cycloheximide | |
| Browning et al. | Disulfide scrambling of interleukin-2: HPLC resolution of the three possible isomers | |
| ES2009588A6 (es) | Un metodo para la preparacion de un polipeptido. | |
| HUT50195A (en) | New peptites hindering the activity of immune system and medical compositions containing them and process for production of these peptides and compositions | |
| IL88378A (en) | Human interferon-gamma binding proteins their manufacture and pharmaceutical compositions comprising them | |
| EP0330700A4 (en) | Human prourokinase-like polypeptide. | |
| AU585167B2 (en) | Novel substrate peptides | |
| IE60670B1 (en) | Homogeneous recombinant immune interferon fragments | |
| ATE53606T1 (de) | Mit einem herpes-simplex-virus-gen inseriertes rekombinantes plasmid. | |
| EP0238275A3 (en) | Recombinant product | |
| AU4405689A (en) | New limphokines, dna sequences coding for said limphokines and pharmaceutical compositions containing said limphokines | |
| MX9709846A (es) | Secuencias de acidos nucleico y aminoacidos relacionados con el helicobacter pylori para procedimientos de diagnostico y terapeuticos. |